Taking Mounjaro and Clonazepam Together: Key Considerations

Mounjaro (tirzepatide) slows gastric emptying, which has the potential to alter the absorption rate of orally taken medicines including some benzodiazepines.
Clonazepam is a long-acting benzodiazepine with a narrow therapeutic window, making consistent absorption particularly important for people managing epilepsy or anxiety disorders.
No specific pharmacokinetic trial has studied tirzepatide and clonazepam head-to-head; clinical judgement based on your individual circumstances is therefore essential.
A prescriber reviewing both medicines is the right step — not stopping either without medical guidance, and not starting Mounjaro without disclosing your current medicines.

If you are already prescribed clonazepam and your prescriber is now considering Mounjaro for weight management, you are right to ask about the combination. Mounjaro (tirzepatide) slows gastric emptying, which can alter how quickly other medicines are absorbed — and for a medicine like clonazepam, where consistent blood levels matter, that is a question worth taking seriously. These are both prescription-only medicines, so any decision about taking them together rests with a prescriber who can review your full clinical picture. The NHS patient information for tirzepatide advises telling your doctor or pharmacist about every medicine you take before starting treatment.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How gastric emptying changes affect medicines you already take on Mounjaro

You take your clonazepam every morning, and now Mounjaro is on the table

Picture your usual routine: clonazepam at a fixed time, sometimes with breakfast, because that is the habit that works. Then your prescriber raises the possibility of Mounjaro. The reasonable question that follows is not whether weight management treatment is a good idea, but whether a medicine that changes the pace of your digestion could interfere with something as sensitive as an anticonvulsant or anxiolytic you have been stable on for months or years.

Mounjaro acts on two gut-hormone receptors, GIP and GLP-1. One of the downstream effects of activating those receptors is a slowing of gastric emptying, food and anything else in the stomach moves into the small intestine more slowly than usual. For most medicines this is a modest effect, but for medicines with narrow therapeutic windows or steep dose-response curves, even moderate changes in absorption timing can matter. Clonazepam falls into that category: too little absorbed too slowly could theoretically reduce its effectiveness; altered peak levels could affect tolerability.

The BNF entry for tirzepatide notes the gastric-emptying effect and flags that clinicians should monitor co-administered medicines that depend on threshold plasma concentrations. That is not a prohibition, it is a prompt for clinical review, which is exactly the conversation to have before any new prescription is written. If you are exploring what a Mounjaro consultation involves, our frequently asked questions cover what prescribers typically assess during a first review.

What the evidence actually says, and where the gaps are

Here it is worth being precise about what is known and what is extrapolated. The clinical trials for tirzepatide tested the effect of gastric slowing on a small panel of orally administered medicines, including oral contraceptives. The slowing effect on those test medicines was real but modest, and it was most pronounced during the first four weeks of treatment and in the four weeks following each dose increase, the periods when the body is adapting to a new dose level.

Clonazepam has not been included in a dedicated pharmacokinetic sub-study with tirzepatide. What is known comes from the general mechanism: benzodiazepines are absorbed in the small intestine, so a delay in gastric transit could push the time-to-peak-plasma-level out. For someone whose seizure control or anxiety management depends on predictable drug levels, that delay is worth factoring in. It does not automatically mean the combination is unsuitable, many people take multiple medicines alongside Mounjaro. It means the prescriber needs to know.

If you have questions about how Mounjaro interacts with other medicines in a similar class, the page on Mounjaro and diazepam covers some of the same gastric-absorption territory for another benzodiazepine. The underlying mechanism is shared, though the two medicines differ in half-life and clinical use. There is also a related discussion on taking diazepam alongside Mounjaro that explores prescriber decision-making in more detail.

Practical steps before combining these two medicines

The single most useful thing you can do right now takes less than a minute: check the patient information leaflet for your clonazepam brand and make a note of any interactions listed with medicines affecting gut motility or absorption. Then do the same for Mounjaro. Neither leaflet will say every combination is tested, but cross-referencing them gives you the right questions to bring to your prescriber, rather than relying on a general internet search.

Beyond that, the practical guidance is straightforward. Tell your prescriber or GP that you take clonazepam before any Mounjaro prescription is written. If treatment does go ahead, your prescriber may want to time doses to minimise overlap or monitor more closely in the early weeks, and if you notice unexpected sensations such as ear pressure or hearing changes, our page on Mounjaro and clogged ears explains why some people experience this and when to seek advice. Do not adjust your clonazepam dose or timing yourself to accommodate Mounjaro, that decision belongs with the clinician who manages your neurological or mental health care.

For a broader picture of what the Mounjaro treatment journey involves, the tirzepatide overview on our site covers how the medicine works, its licensed schedule and what clinical review looks like at each stage. If renal function is something your GP monitors alongside your existing medicines, the page on tirzepatide and renal impairment is also worth reading before your consultation.

Mounjaro is a prescription-only medicine licensed for weight management in adults, and every prescription from our pharmacy follows a same-day clinical review by a GPhC-registered Independent Prescriber, a real clinician reads your answers and your medicine history, not a piece of software. If cost is a factor in your thinking, the Mounjaro price comparison page sets out how private treatment is typically priced and what a legitimate prescription service includes. When you are ready, check your eligibility with our prescribers.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions